Agenda

Thursday, October 31, 2024 All times in Eastern Time
7:00 am	Registration/Continental Breakfast/Exhibits
8:00 am	Welcome and Announcements Lars G. Svensson, MD, PhD
Session I: Prevention and Management of CV Risk Part 1 Moderator: Amy Zack, MD
8:15 am	Tools in CVD Prevention and Risk Management: To Test or Not to Test? Lp(a),apoB, Non HDL-C Leslie Cho, MD
8:30 am	Statin Initiation for Primary Prevention Among Statin Naïve Adults and Reasons for Nonadherence Vikas Sunder, MD
8:45 am	When Statins Are Not Enough – Non-statin Lipid Lowering Therapies to Manage Residual Risk Ashish Sarraju, MD
9:00 am	Keto, Low Carb, Plant Based, IF: Controversies in the Evidence for the “Best “Diet: What is the Evidence and How to Apply in Clinical Practice Julia Zumpano, RD, LD
9:15 am	Weight Loss Pharmacotherapy: Utilizing Current Therapies and Exploring the Next Generation of Weight Loss Medications Steve Nissen, MD
9:30 am	Managing Anti-Hyperglycemic and CV Risk Reduction Agents in Patients With Diabetes: SGLT2i or GLP1RA or Both? Dennis Bruemmer, MD, PhD
9:45 am	Old and Evolving Strategies for Treatment-Resistant Hypertension Luke Laffin, MD
10:00 am	Social Determinants of Health and Cardiovascular Disease: Current State and Future Directions Lee Kirksey, MD
10:15 am	Panel Discussion/Q&A Session Faculty
10:35 am	Refreshment Break/Exhibits
Session II: Prevention and Management of Risk Part 2 Moderator: Leslie Cho, MD
10:55 am	Hormone Therapy and Heart Health: Debunking Myths, Embracing Evidence Leslie Cho, MD
11:05 am	The Intersection of Cardiovascular Disease and Chronic Kidney Disease: Strategies for Reducing Cardiovascular Risk Crystal Gadegbeku, MD
11:20 am	Who Should Get a CAC? How Often? How to Use the Results to Assess Risk? Milind Desai, MD
11:35 am	Management of CV Issues in the Elderly: Geriatric Cardiology Ardeshir Hashmi, MD
11:50 am	Population Health Management: Interventions to Control Cardiovascular Disease Risk Factors: Current Status LeRoi Hicks, MD
12:05 pm	Panel Discussion/Q&A Session Faculty
12:25 pm	Lunch
Session III: Special Populations Moderator: Deirdre Mattina, MD
1:25 pm	Cardiac Disease Remains the Leading Cause of Mortality in Women: What are we Doing to Address This? Leslie Cho, MD
1:40 pm	Cardiovascular Disease and Pregnancy: Optimizing Maternal and Fetal Health Deirdre Mattina, MD
1:55 pm	Competitive Sports Participation in Athletes with Heart Disease: Evaluation and Management Tamanna Singh, MD
2:05 pm	Cardio-oncology: Optimizing the Balance Between Cancer Outcomes and Cardiac Success Patrick Collier, MD, PhD
2:20 pm	Panel Discussion/Q&A Session Faculty
2:35 pm	Refreshment Break/Exhibits
Session IV: Essentials of CVD Moderator: Venu Menon, MD
2:55 pm	Role of Advanced Imaging for Ischemic Heart Disease: CT, CMR, Nuclear and Advanced Echocardiography Saberio Lo Presti Vega, MD
3:10 pm	Creating a Pathway for the Management of Stable Angina in Your Clinic: Structured Risk Assessment and Clinical Decision Making Ben Alencherry, MD
3:25 pm	ANOCA, INOCA, MINOCA: What Does It All Mean? Diagnostic Testing and Therapeutic Management Khalid Ziada, MD
3:40 pm	How Do I Manage my Post MI Patient (Including DAPT Guidelines/Duration/CardiacRehab) Venu Menon, MD
3:55 pm	Cardiac Rehab: Why it is Critical and How Can We Improve Access and Compliance? Erik Van Iterson, PhD, MS
4:10 pm	Peripheral Artery Disease: Assessment and Clinical Decision Making Lee Kirksey, MD
4:25 pm	Panel Discussion/Q&A Session Faculty
4:40 pm	Adjourn

Back to top

Friday, November 1, 2024 All times in Eastern Time
7:00 am	Continental Breakfast/Exhibits
8:00 am	Welcome and Announcements
Session V: Structural Heart Disease Moderator: Samir Kapadia, MD
8:10 am	Aortic Stenosis: Diagnosis and Management in the Modern Era Samir Kapadia, MD
8:25 am	MR: How to Diagnose and Manage Mitral Valve Disease: When to Refer? What are the Options L. Leonardo Rodriguez, MD
8:40 am	What to Know About the Natural History of Tricuspid Regurgitation: Current and Future Management Strategies Amar Krishnaswamy, MD
8:55 am	Bicuspid and Aneurysm-Associated Aortic Valve Disease: Timing of Intervention and the Role of Family Screening Milind Desai, MD
9:05 am	Guidelines for Anticoagulation Following Structural Heart Therapies Grant Reed, MD, MSc
9:20 am	Hypertrophic Cardiomyopathy: Co-management in the Era of Emerging Precision Therapies Milind Desai, MD
9:35 am	Panel Discussion/Q&A Session Faculty
9:50 am	Refreshment Break/Exhibits
Session VI: Heart Failure Moderator: Amanda Vest, MBBS
10:30 am	Heart Failure Stages, Phenotypes and Diagnosis and How to Screen for HF in the Primary Care Setting Randall Starling, MD
10:45 am	HFrEF: Essentials of Guideline Directed Medical Therapy Initiation and Titration Amanda Vest, MBBS
11:00 am	Managing Comorbidities in HF: Frailty, Anemia, Sleep Apnea, AF, Obesity Karlee Hoffman, DO
11:15 am	Essentials of Diagnosis and Management for HFpEF Sanjeeb Bhattacharya, MD
11:30 am	Diagnosis and Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Mazen Hanna, MD
11:45 am	Strategies to Enhance GDMT Implementation and Adherence M. Trejeeve Martyn, MD
12:00 pm	Managing Long Term LVADs and Transplant Recipients in the Community Setting Ike Okwuosa, MD
12:15 pm	The Importance of Collaboration Between EP and HF: CRT and Novel Pacing Thomas Callahan, MD
12:30 pm	Panel Discussion/Q&A Session Faculty
12:50 pm	Lunch
Session VII: Heart Rhythm Moderator: Mohamed Kanj, MD
1:50 pm	Diagnosis and Management of New-Onset Atrial Fibrillation Mohamed Kanj, MD
2:05 pm	AF and Left Atrial Appendage Closure: Current and Future Directions Mohamed Kanj, MD
2:20 pm	What I Need to Know to Evaluate and Manage the Patient With PVCs and SVT Pasquale Santangeli, MD, PhD
2:35 pm	Evaluation and Management of Syncope in the Young Adult Kenneth Mayuga, MD
2:50 pm	Follow-Up of Pacemakers and ICDs For the Non-Electrophysiologist Kevin F. Kwaku, MD, PhD
3:05 pm	Wearables for Arrhythmia Care: Current Challenges and Future Prospects Niraj Varma, MD, PhD
3:20 pm	Panel Discussion/Q&A Session Faculty
3:35 pm	Adjourn

Back to top